Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
V. P. Kolosov, E. Y. Kochegarova, S. V. Naryshkina (Blagoveschensk, Russian Federation). Prediction of complications development and lethal outcome in patients with community-acquired pneumonia. Eur Respir J 2011; 38: Suppl. 55, 493

Member's Comments

No comment yet.

Related content which might interest you: Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 42s Year: 2007 Risk factors for early onset severe community-acquired pneumonia complications Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018 Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Source: Eur Respir J 2009; 33: 153-159 Year: 2009 Another view on the prediction of outcomes in patients with community-acquired pneumonia Source: Eur Respir J 2011; 38: 992-993 Year: 2011 Another view on the prediction of outcomes in patients with community-acquired pneumonia Source: Eur Respir J 2011; 38: 991-992 Year: 2011 Biomarkers in severe community-acquired pneumonia (SCAP) prognosis, complications and outcomes Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients Source: Eur Respir J 2004; 24: Suppl. 48, 548s Year: 2004 Biomarkers as complication predictors in community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Prediction of prognosis in healthcare-associated pneumonia Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Causes and predictors of treatment failures in patients with ICU-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 16s Year: 2002 Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia Source: Eur Respir J 2009; 34: 932-939 Year: 2009 Intrahospital cardiovascular complications in severe community-acquired pneumonia Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia Source: Eur Respir J 2007; 30: 517-524 Year: 2007 The impact of patients‘ age and concomitant diseases on community-acquired pneumonia outcome Source: Eur Respir J 2007; 30: Suppl. 51, 675s Year: 2007 Inflammatory responses predict long-term mortality risk in community-acquired pneumonia Source: Eur Respir J 2011; 37: 1439-1446 Year: 2011 Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Mortality in patients with ventilator-associated pneumonia (VAP) and severe sepsis is determined by the number of organ failures Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Effect of corticoids on the clinical course and outcome of severe community-acquired pneumonia Source: Annual Congress 2004 - SARS and other lower respiratory tract infections Year: 2004 Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009